sparfloxacin has been researched along with Cervical Tuberculous Lymphadenitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erbes, R; Lode, H; Lubasch, A; Mauch, H | 1 |
1 other study(ies) available for sparfloxacin and Cervical Tuberculous Lymphadenitis
| Article | Year |
|---|---|
Sparfloxacin in the treatment of drug resistant tuberculosis or intolerance of first line therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antitubercular Agents; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |